| Date Filed | Type | Description |
| 08/22/2023 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 15,335 shares
@ $1.3037, valued at
$20k
|
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 600 shares
@ $4.9408, valued at
$3k
|
|
| 03/24/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 2,197 shares
@ $5.4627, valued at
$12k
|
|
| 02/14/2022 |
SC 13G/A
| Pridgen William reports a 8.7% stake in Virios Therapeutics, Inc. |
| 01/28/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 4,180 shares
@ $5.9803, valued at
$25k
|
|
| 01/04/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 2,215 shares
@ $5.4329, valued at
$12k
|
|
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G
| Pridgen William reports a 8.5% stake in Virios Therapeutics, Inc. |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 1,500 shares
@ $11.98, valued at
$18k
|
|
| 12/16/2020 |
3
| Pridgen William (Director) has filed a Form 3 on Virios Therapeutics, LLC |